CLINICAL_TRIALS
trial_result
· 2021-07-20
Clinical Trial Update: Phase 1/2 Sequentially Staged Safety Study in Healthy Subjects and Subjects With Mild Acne [Phase 1, Phase 2]
Summary
Phase 1/2 sequential safety study in healthy subjects and subjects with mild acne completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Dermira, Inc. | Conditions: Acne | Phase 1, Phase 2 | Status: COMPLETED